Blocking microglial reactivity via purinergic receptors prevents subacute cognitive deficits after TIA.
EMBO molecular medicine
View this publicationEMBO molecular medicine
View this publicationNature immunology
View this publicationLipids in health and disease
View this publicationBiochemical and biophysical research communications
View this publicationHGG advances
View this publicationNature immunology
View this publicationCurrent opinion in immunology
View this publicationSTAR protocols
View this publicationBrain : a journal of neurology
View this publicationTrends in biotechnology
View this publication